Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite Appropriate Medical and Surgical Treatment.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Women and men over 18 years old~2. Suffering from severe and recurrent Chronic Rhinosinusitis with Nasal Polyps despite having benefited from the appropriate medical and surgical treatment.~3. CRSwNP diagnosis established on the basis of clinical presentation and patient interrogation by their referent ENT surgeon.~4. Patient treated with Dupilumab in the indication depicted in bullet point 2.~5. Patient having voiced their non-opposition to this research, having received clear and appropriate information.~6. Patient affiliated to the French Social Security.~Exclusion Criteria:~1. Patient having undergone endoscopic nasal surgery during their Dupilumab treatment.~2. Patient presenting exclusion criteria for Dupilumab treatment.~3. Patient suffering from immune deficit.~4. Patient suffering from vascularitis with nasal expression.~5. Patient whose autonomy has been reduced by a legal authority.~6. Patient unable to express their agreement to participate in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients suffering from severe recurrent CRSwNP and treated with Dupilumab (Type: None): Patients suffering from severe recurrent CRSwNP despite having benefited from the appropriate medical and surgical treatment and treated with Dupilumab for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).